Research Article
Efficacy of Recombinant Human Endostatin plus Neoadjuvant Chemotherapy for Osteosarcoma and Its Influence on Serum VEGF and MMP-9 Levels
Table 4
Comparison of limb function.
| | Score | Excellent | Good | Fair | Poor | Excellent rate |
| Control group (n = 65) | 24.12 ± 2.31 | 29 (44.6) | 12 (18.5) | 14 (21.5) | 10 (15.4) | 41 (63.1) | Combination group (n = 76) | 27.64 ± 2.84 | 43 (56.6) | 17 (22.4) | 7 (9.2) | 9 (11.8) | 60 (79.0) | χ 2/t | 7.9847 | | | | | 4.3431 | | <0.0001 | | | | | 0.0372 |
|
|